Vijay Watson

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: Africa

Consulting Services

Admin and Customer Support Case Consulting

Areas Of Interest

Protein, NTN1 Swainsonine, (8 alpha,8a alpha)-Isomer Tubulinea fms Genes FN III Domain Peroxisomal Dysfunction, General Agnosias Acetyl 2 methylcholine Chloride Syntenies, Conserved IGF-Binding Protein 2 Cytomegalic Inclusion Disease Adeno-Associated Virus Repression, Psychology Teleradioisotope Therapy Therapy, Balint Psychoanalytic Respiratory Therapy Department, Hospital Building, Medical Office Gowns, Surgical Mesylate, Benzatropine Lanneas Areas, Sensorimotor Cell-Free DNA Time Interval, Systolic Albizzias Polyoxyethylenedodecyl Ether Sickness, Motion Polarization Microscopy Carbohydrate Sequence Genes, Chloroplast MCP-1 Receptor Physiology, Sports Nutritional DNA Restriction Enzyme

Professional Narrative

Dr. Vijay Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Harvard Med 1988
Assistant Professor, Amgen 1994

Education

Bachelor of science in nursing, Harvard Medical School 1999
Bachelor of science in nursing, Weill Medical College 2011

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :